This mechanism reveals that ARL4C is not merely a signaling activator but also employs self-protective strategies to sustain expression within the tumor microenvironment, offering a novel rationale for therapeutic targeting and highlighting DUBs as alternative intervention points. The gene discussed is ARL4C; the disease is neoplasm.